Home/Pipeline/Diclofenac Potassium Powder for Oral Solution

Diclofenac Potassium Powder for Oral Solution

Pain

ApprovedActive

Key Facts

Indication

Pain

Phase

Approved

Status

Active

Company

Patrin Pharma

About Patrin Pharma

Patrin Pharma is a private, commercial-stage generic drug company founded in 2018 and headquartered in San Diego, with significant operational facilities in the greater Chicago area. The company specializes in 'practical innovation' within niche generic markets, including complex formulations like oral solutions and topical products, often targeting controlled substances and first-to-market opportunities. It has a track record of FDA approvals, manages Paragraph IV challenges, and grows through strategic partnerships in development, manufacturing, and distribution. Its business model is fully commercial, generating revenue from its marketed products.

View full company profile

Therapeutic Areas

Neurology Pain Management Endocrinology Dermatology Women's Health Gastrointestinal

Other Pain Drugs

Drug	Company	Phase	Status
Oxycodone Patch	Avecho Biotechnology	Preclinical	Active
Oxymorphone Patch	Avecho Biotechnology	Preclinical	Active
Desmetramadol	Syntrix Pharmaceuticals	Clinical Development	Active
CG001419	Cullgen	Phase 1	Active
Proprietary Pain Program(s)	Oblique Therapeutics	Pre-clinical	Active
Pain Management APIs	Noramco	Commercial	Active
Dipendium (Diclofenac Potassium)	NovaMedica	Approved	Active
Na ion channel TicTACs	Solu Therapeutics	Preclinical	Active
Infusional Pain Management (e.g., Paracetamol)	Galenica Senese	Commercial	Active
NCEs for Pain Management	Ipca Laboratories	Preclinical/Discovery	Active
XEN1701	Xenon Pharmaceuticals	Phase 1	Clinical trial initiated